Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022)

23 views

Published on

The US ambulatory ECG market is set to experience favorable growth driven by factors such rising ageing population. For more mail: vikas@konceptanalytics.com

Published in: Business
  • Be the first to comment

  • Be the first to like this

US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022)

  1. 1. US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook ----------------------------------------- (2018-2022) Industry Research by Koncept Analytics 1 January 2018 US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022)
  2. 2. Executive Summary 2 US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022) The ambulatory ECG records the electrical activity of heart while walking (ambulatory) and doing normal activities. In contrast to the usual 12 lead ECG, where the heart’s electrical signals are captured for only a few seconds, the continuous ambulatory ECG monitor can record such signals over a prolonged period at the patient’s own home or work environment. Ambulatory ECG monitoring, which can be performed using a variety of techniques for as short as 24 to 48 hours and for as long as months to years, offers the opportunity to review cardiac ECG data during normal routine activity, including any physical and psychological stresses. Ambulatory ECG monitoring for longer periods (when compared with standard ECG for a 10-second time period) is more sensitive for detecting spontaneous, often highly variable cardiac arrhythmias or conduction abnormalities. Current ambulatory ECG monitoring technologies include traditional Holter, event monitors, mobile cardiac outpatient telemetry (MCOT) and implantable loop recorders. The US ambulatory ECG market is set to experience favorable growth driven by factors such rising ageing population, increasing health care expenditure, accelerating economic growth, growing burden of atrial fibrillation and rise in prevalence of cardiovascular disorders. The major trends observed in this market include technological advancements, increased demand for home based monitoring systems product innovation- PocketECG. However, the growth of this budding is constrained by challenges such as high competition, stringent regulations and high barriers to entry. The report “The US Ambulatory ECG Market: Industry Analysis & Outlook (2018-2022)” analyses the development of this market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: BioTelemetry, Inc., Koninklijke Philips N.V, iRhythm Technologies Inc. and Medtronic Plc. are being profiled along with their key financials and strategies for growth.
  3. 3. Rising aging population and increasing healthcare expenditure supported growth of US ambulatory ECG market.. 3US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022) • The US Ambulatory ECG market is estimated to reach ..million units in 2022, increasing from ..million units in 2018, recording growth at a CAGR of ..% for the period spanning 2018-2022. • By device, traditional holter held the market share of ..% followed by event monitors and MCOT with ..% shares respectively for the year 2017. • The US traditional holter market is predicted to reach ..million units in 2022, increasing from ..million units in 2018, recording growth at a CAGR of ..% for the period spanning 2018-2022. The US Ambulatory ECG Market by Device (2017) The US Ambulatory ECG Market Forecast by Volume (2018- 2022) The US Traditional Holter Market Forecast by Volume (2018-2022)
  4. 4. Growing burden of Atrial Fibrillation and rise in the prevalence of cardiac disorders will drive the market for ambulatory ECG in the US.. 4 US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018- 2022) • By indication, AF (Atrial Fibrillation) symptoms held the market share of ..% followed by Syncope with ..% share in 2017. • The US ambulatory ECG market by AF symptoms is estimated to reach ..million units in 2022, increasing from ..million units in 2018, recording growth at a CAGR of ..% for the period spanning 2018-2022. • The US ambulatory ECG market by Syncope is projected to reach ..thousand units in 2022, increasing from ..thousand units in 2018, recording growth at a CAGR of ..% for the period spanning 2018-2022. The US Ambulatory ECG Market Forecast by AF Symptoms (2018-2022) ) The US Ambulatory ECG Market by Indication (2017) The US Ambulatory ECG Market Forecast by Syncope (2018-2022)
  5. 5. Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9871694789 vikas@konceptanalytics.com Contact Us: www.konceptanalytics.com This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy. For Report Purchase Click Below: http://www.konceptanalytics.com/Researchreport/us-ambulatory-electrocardiography-ecg-market- industry-analysis-outlook-2018-2022-35477.aspx Disclaimer

×